Regentis Biomaterials LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
AMEX
Susan Alpert, a Director of Regentis Biomaterials Ltd., received 24,826 shares of common stock on July 9, 2026.
AMEX
Pini Ben-Elazar, a Director of Regentis Biomaterials Ltd., reported multiple transactions in common stock on July 9, 2026.
AMEX
Keith Valentine, a Director of Regentis Biomaterials Ltd., received 24,826 shares of common stock on July 9, 2026.
AMEX
Jeff Dykan, a Director of Regentis Biomaterials Ltd., reported multiple transactions in common stock on July 9, 2026.
AMEX
Ehud Geller, Chief Executive Officer and a Director of Regentis Biomaterials Ltd., received 31,250 shares of common stock on July 9, 2026.
AMEX
Efraim Cohen-Arazi, a Director of Regentis Biomaterials Ltd., received 24,826 shares of common stock on July 9, 2026.